Literature DB >> 25348064

Primary age-related tauopathy (PART): a common pathology associated with human aging.

John F Crary1, John Q Trojanowski, Julie A Schneider, Jose F Abisambra, Erin L Abner, Irina Alafuzoff, Steven E Arnold, Johannes Attems, Thomas G Beach, Eileen H Bigio, Nigel J Cairns, Dennis W Dickson, Marla Gearing, Lea T Grinberg, Patrick R Hof, Bradley T Hyman, Kurt Jellinger, Gregory A Jicha, Gabor G Kovacs, David S Knopman, Julia Kofler, Walter A Kukull, Ian R Mackenzie, Eliezer Masliah, Ann McKee, Thomas J Montine, Melissa E Murray, Janna H Neltner, Ismael Santa-Maria, William W Seeley, Alberto Serrano-Pozo, Michael L Shelanski, Thor Stein, Masaki Takao, Dietmar R Thal, Jonathan B Toledo, Juan C Troncoso, Jean Paul Vonsattel, Charles L White, Thomas Wisniewski, Randall L Woltjer, Masahito Yamada, Peter T Nelson.   

Abstract

We recommend a new term, "primary age-related tauopathy" (PART), to describe a pathology that is commonly observed in the brains of aged individuals. Many autopsy studies have reported brains with neurofibrillary tangles (NFTs) that are indistinguishable from those of Alzheimer's disease (AD), in the absence of amyloid (Aβ) plaques. For these "NFT+/Aβ-" brains, for which formal criteria for AD neuropathologic changes are not met, the NFTs are mostly restricted to structures in the medial temporal lobe, basal forebrain, brainstem, and olfactory areas (bulb and cortex). Symptoms in persons with PART usually range from normal to amnestic cognitive changes, with only a minority exhibiting profound impairment. Because cognitive impairment is often mild, existing clinicopathologic designations, such as "tangle-only dementia" and "tangle-predominant senile dementia", are imprecise and not appropriate for most subjects. PART is almost universally detectable at autopsy among elderly individuals, yet this pathological process cannot be specifically identified pre-mortem at the present time. Improved biomarkers and tau imaging may enable diagnosis of PART in clinical settings in the future. Indeed, recent studies have identified a common biomarker profile consisting of temporal lobe atrophy and tauopathy without evidence of Aβ accumulation. For both researchers and clinicians, a revised nomenclature will raise awareness of this extremely common pathologic change while providing a conceptual foundation for future studies. Prior reports that have elucidated features of the pathologic entity we refer to as PART are discussed, and working neuropathological diagnostic criteria are proposed.

Entities:  

Mesh:

Year:  2014        PMID: 25348064      PMCID: PMC4257842          DOI: 10.1007/s00401-014-1349-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  148 in total

1.  Age and histopathologic heterogeneity in Alzheimer's disease. Evidence for subtypes.

Authors:  W Bondareff; C Q Mountjoy; M Roth; M N Rossor; L L Iversen; G P Reynolds
Journal:  Arch Gen Psychiatry       Date:  1987-05

Review 2.  Senile dementia with tangles (tangle predominant form of senile dementia).

Authors:  K A Jellinger; C Bancher
Journal:  Brain Pathol       Date:  1998-04       Impact factor: 6.508

3.  Olfactory involvement in aging and Alzheimer's disease: an autopsy study.

Authors:  Johannes Attems; Felix Lintner; Kurt A Jellinger
Journal:  J Alzheimers Dis       Date:  2005-04       Impact factor: 4.472

4.  Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.

Authors:  Mari Yoshida
Journal:  Neuropathology       Date:  2006-10       Impact factor: 1.906

5.  Spinal cord neurofibrillary pathology in Alzheimer disease and Guam Parkinsonism-dementia complex.

Authors:  M L Schmidt; V Zhukareva; D P Perl; S K Sheridan; T Schuck; V M Lee; J Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  2001-11       Impact factor: 3.685

Review 6.  Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways.

Authors:  P R Hof; B A Vogt; C Bouras; J H Morrison
Journal:  Vision Res       Date:  1997-12       Impact factor: 1.886

Review 7.  Alzheimer's disease-related lesions.

Authors:  Irina Alafuzoff
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects.

Authors:  C Bancher; K A Jellinger
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Dementia: a word to be forgotten.

Authors:  Don I Trachtenberg; John Q Trojanowski
Journal:  Arch Neurol       Date:  2008-05

10.  Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.

Authors:  Angela L Guillozet; Sandra Weintraub; Deborah C Mash; M Marsel Mesulam
Journal:  Arch Neurol       Date:  2003-05
View more
  496 in total

1.  Methionine Sulfoxide Reductase-B3 (MsrB3) Protein Associates with Synaptic Vesicles and its Expression Changes in the Hippocampi of Alzheimer's Disease Patients.

Authors:  Stephanie L Adams; Laurent Benayoun; Kathy Tilton; Olivia R Chavez; Jayandra J Himali; Jan Krzysztof Blusztajn; Sudha Seshadri; Ivana Delalle
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 2.  Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau.

Authors:  Keith A Josephs
Journal:  Mayo Clin Proc       Date:  2017-08       Impact factor: 7.616

3.  Suspected non-AD pathology in mild cognitive impairment.

Authors:  Laura E M Wisse; Nirali Butala; Sandhitsu R Das; Christos Davatzikos; Bradford C Dickerson; Sanjeev N Vaishnavi; Paul A Yushkevich; David A Wolk
Journal:  Neurobiol Aging       Date:  2015-09-07       Impact factor: 4.673

4.  Association of APOE with tau-tangle pathology with and without β-amyloid.

Authors:  Jose M Farfel; Lei Yu; Philip L De Jager; Julie A Schneider; David A Bennett
Journal:  Neurobiol Aging       Date:  2015-09-28       Impact factor: 4.673

5.  Evaluating and treating neurobehavioral symptoms in professional American football players: Lessons from a case series.

Authors:  Raquel C Gardner; Katherine L Possin; Christopher P Hess; Eric J Huang; Lea T Grinberg; Amber L Nolan; Brendan I Cohn-Sheehy; Pia M Ghosh; Serggio Lanata; Jennifer Merrilees; Joel H Kramer; Mitchel S Berger; Bruce L Miller; Kristine Yaffe; Gil D Rabinovici
Journal:  Neurol Clin Pract       Date:  2015-08

Review 6.  Tauopathies as clinicopathological entities.

Authors:  David J Irwin
Journal:  Parkinsonism Relat Disord       Date:  2015-09-08       Impact factor: 4.891

Review 7.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

8.  Brain atrophy in primary age-related tauopathy is linked to transactive response DNA-binding protein of 43 kDa.

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Stephen D Weigand; David S Knopman; Ronald C Petersen; Clifford R Jack; Jennifer L Whitwell; Dennis W Dickson
Journal:  Alzheimers Dement       Date:  2019-05-02       Impact factor: 21.566

Review 9.  Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.

Authors:  Mansi R Khanna; Jane Kovalevich; Virginia M-Y Lee; John Q Trojanowski; Kurt R Brunden
Journal:  Alzheimers Dement       Date:  2016-10       Impact factor: 21.566

Review 10.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.